PMID: 488757Jul 1, 1979Paper

Antipyrine clearance per unit volume liver: an assessment of hepatic function in chronic liver disease

Gut
M HomeidaR A Branch

Abstract

Liver size has been estimated clinically and by a non-invasive ultrasound technique in 16 normal subjects, 16 patients with cirrhosis, 10 patients with chronic biliary obstruction, and three patients with primary hepatoma. Antipyrine disposition was also measured in each subject. Hepatomegaly was not clinically detectable until there was approximately a 20% increase in liver size. Additional increases in size correlated significantly with clinical estimates of hepatomegaly. Antipyrine clearance had a three-fold range in normal subjects. Its mean value was significantly reduced in each subgroup of patients with liver disease. However, 48% of patients with liver disease had values within the normal range. In normal subjects there was a significant correlation between antipyrine clearance and liver volume. Thus, intersubject variation in clearance normalised for liver volume was less than clearance alone. Antipyrine clearance normalised for liver volume in patients with liver disease was significantly lower than in normal subjects and there was no overlap with normal subjects. In conclusion, assessment of drug metabolising efficiency per unit volume of liver increased the discrimination in differentiating subjects with normal from...Continue Reading

References

Aug 1, 1977·European Journal of Clinical Investigation·E A SotaniemiE Viljakainen
Jan 1, 1978·Annual Review of Medicine·A M HoyampaS Schenker
Jan 1, 1975·Drug Metabolism Reviews·G R Wilkinson, S Schenker
Apr 20, 1977·European Journal of Clinical Pharmacology·E A SotaniemiP V Luoma
Oct 1, 1975·Clinical Pharmacology and Therapeutics·G R Wilkinson, D G Shand
Oct 1, 1975·Clinical Pharmacology and Therapeutics·R E VestalR Andres
Jan 30, 1976·European Journal of Clinical Investigation·P B Andreasen, G Greisen
Mar 1, 1972·European Journal of Clinical Pharmacology·B SchoeneH F von Oldershausen
Nov 2, 1972·The New England Journal of Medicine·E S Vesell
Dec 1, 1974·Clinical Pharmacology and Therapeutics·P B Andreasen, E S Vesell
Apr 1, 1974·European Journal of Clinical Investigation·P B AndreasenN Tygstrup
Jul 5, 1968·Science·E S Vesell, J G Page
Jan 1, 1950·Current Researches in Anesthesia & Analgesia·B B BRODIEL C MARK
Jan 1, 1949·The Biochemical Journal·D K Chaudhuri, E Kodicek

❮ Previous
Next ❯

Citations

Jan 1, 1984·Cancer Chemotherapy and Pharmacology·M W TeunissenD D Breimer
Jan 1, 1992·European Journal of Clinical Pharmacology·G M Robertz-VaupelH J Dengler
Oct 1, 1982·European Journal of Drug Metabolism and Pharmacokinetics·A P NarangV S Mathur
Jan 1, 1989·Pharmacology & Therapeutics·D S Sitar
Sep 1, 1996·Journal of Hepatology·R JalanH J Hodgson
Jun 1, 1992·International Journal of Dermatology·A C VerschuurR A Chamuleau
Jan 1, 1993·Pharmacology & Toxicology·J Sonne
Nov 1, 1991·Biopharmaceutics & Drug Disposition·M Hartleb
Jan 1, 1991·Drug Metabolism Reviews·A P NarangP Bambery
Aug 1, 1986·European Journal of Clinical Investigation·P SpoelstraD D Breimer
Nov 1, 1984·British Journal of Clinical Pharmacology·M W TeunissenD D Breimer
Dec 1, 1984·British Journal of Clinical Pharmacology·H I PirttiahoP V Luoma
May 1, 1987·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J B GrossA Zimmermann
Apr 17, 2003·Intensive Care Medicine·Joseph A CarcilloGilbert J Burckart
Oct 9, 2008·Laboratory Animals·T H YoungO Y P Hu
Oct 27, 2018·Journal of Medicine and Life·Craita Isabela AndronescuPetru Aurel Babes
Oct 5, 2019·Clinical Pharmacokinetics·Jaydeep SinhaHesham S Al-Sallami
Jun 1, 1995·Alimentary Pharmacology & Therapeutics·R Jalan, P C Hayes
Jan 1, 1982·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·R A Branch

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.